Rein Therapeutics, Inc. reports

Company location: Austin, TX
Fiscal year end: 31 December

Rein Therapeutics, Inc. has filed 525 SEC EDGAR filings since 03 Dec 2007

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 76-100 of 522 matching filings.

Per page

25

Current page

4

10-K/A File 001-38130

10-K/A

Filing date: 30 Apr 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38130

8-K

Filing date: 22 Apr 2025
Reporting date: 21 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38130

8-K

Filing date: 17 Apr 2025
Reporting date: 16 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-38130

10-K

Filing date: 07 Apr 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-K File 001-38130

NT 10-K

Filing date: 31 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38130

8-K

Filing date: 10 Jan 2025
Reporting date: 10 Jan 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 09 Dec 2024
Reporting date: 05 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Dec 2024
Reporting date: 02 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Dec 2024
Reporting date: 02 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Dec 2024
Reporting date: 02 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Dec 2024
Reporting date: 02 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Dec 2024
Reporting date: 02 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 04 Dec 2024
Reporting date: 02 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38130

8-K

Filing date: 14 Nov 2024
Reporting date: 14 Nov 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38130

10-Q

Filing date: 14 Nov 2024
Reporting date: 30 Sep 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13G/A File 005-90032

SCHEDULE 13G/A filing

Filing date: 05 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 22 Aug 2024
Reporting date: 20 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 22 Aug 2024
Reporting date: 20 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 22 Aug 2024
Reporting date: 20 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 22 Aug 2024
Reporting date: 20 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 22 Aug 2024
Reporting date: 20 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38130

8-K

Filing date: 21 Aug 2024
Reporting date: 20 Aug 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38130

8-K

Filing date: 14 Aug 2024
Reporting date: 14 Aug 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38130

10-Q

Filing date: 14 Aug 2024
Reporting date: 30 Jun 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38130

8-K

Filing date: 26 Jul 2024
Reporting date: 26 Jul 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .